CAS RN: 287976-94-7
bis(4-broMophenyl)-4-sec-butylaniline
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250423
50mg / 250mg / 1g / 5g
Confirm by inquiry
Shanghai 8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 287976-94-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Shenzhen
Inquiry
287976-94-7 / N,N-bis(4-bromophenyl)-4-butan-2-ylaniline
Standard CAS: 287976-94-7
Multi CAS: No
Basic Information
copy
CAS
287976-94-7 copy
Multi CAS
No copy
Molecular Formula
C22H21BR2N copy
Molecular Weight
459.200000 copy
Exact Mass
459.002030 copy
InChI
InChI=1S/C22H21Br2N/c1-3-16(2)17-4-10-20(11-5-17)25(21-12-6-18(23)7-13-21)22-14-8-19(24)9-15-22/h4-16H,3H2,1-2H3 copy
InChIKey
APCOQCLKCAFINS-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
25 copy
Aromatic heavy atom count
18 copy
Fraction Csp3
0.18 copy
Rotatable bonds
5 copy
H-bond acceptors
1 copy
Molar refractivity
115.23 copy
TPSA
3.24 copy
LogP / Solubility
WLOGP
8.19 copy
MLOGP
7.24 copy
XLogP3
8.1 copy
Consensus LogP
7.84 copy
Log S (ESOL)
-8.05 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-9.24 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-10.05 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
0.3 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy